The effect of a cardioselective beta-adrenergic blocking agent, metoprololl, on symptoms and exercise tolerance was studied in 16 patients with angina pectoris.
cardiac failure appeared during any of the four treatment periods. Heart volume showed no significant change. Unwanted effects were of the same frequency and severity during treatment with metoprolol at both dose levels as with placebo.
The sixteen patients were included in a long-term tolerance study with unchanged doses of metoprolol and have now been followedfor 24 months without any unwanted effects.
In animal studies, metoprolol has been found to Subjects inhibit the heart rate and contractile force responses Sixteen patients, previously treated with a betato isoprenaline in considerably lower doses than adrenergic blocking drug for angina pectoris for at least were required to block the vasodilator and broncho-three months, entered the study. All had a typical history dilator effects of isoprenaline (Ablad, Carlsson, and of angina pectoris by the criteria of Rose (1962) . The Ek, 1973) . By the criteria of Lands, Luduena, and mean age was 59 years (range 51 to 66 years), and the Buzzo (1967) , metoprolol selectively blocks betal-mean duration of angina pectoris was 6 years (range 6 adrenergic receptors. Metoprolol has been found months to 14 years). Nine patients had previously to be devoid of beta-receptor stimulating properties suffered myocardial infarction and four were treated (Ablad et al., 1973) . Compared with placebo with digoxin because of previous signs of heart failure. metoprolol significantly increased the exercise All patients but one had cardiac volumes within normal tolerance in patients with angina pectoris, in an limits and one was at the upper limit of the normal acute study reported by Adolfsson et al. (1974) . range. Pertinent clinical information is given in Table 1 .
In view of these findings the present study was undertaken to evaluate the effects of metoprolol in Methods patients with angina pectoris in a subacute study. During a run-in period of 3 weeks, the patients were treated with alprenolol 100 mg t.d.s. This was followed by a 3-week period of treatment with placebo and a 3- wise increasing work loads. The exercise tests were A simple diary card, to which the patients had become performed with six minutes at each work load; the inaccustomed during the run-in period, was completed crements of work load were so adjusted that the patients by the patient and returned to the physician at each could complete at least two six-minute exercise periods visit. The diary card showed the number of nitro-before being stopped by chest pain during the third glycerin tablets taken each day, the number of anginal period. Electrocardiograms were monitored continuously attacks, and a daily subjective assessment of angina and recorded intermittently during exercise using six praecordial leads (chest-head (Kjellberg, Lonroth, and Rudhe, 1951 group.bmj.com on April 13, 2017 -Published by http://heart.bmj.com/ Downloaded from (P < 0.02) (Fig. 2) and with the dosage of 50 mg Work load at break point, the highest calculated t.d.s. (P <0.001) (Fig. 3) . load tolerated for 6 minutes (Ekelund, Melcher, and The general preference at the end of each period Oro, 1974) Table 3 . improvement in exercise tolerance when the second placebo period was compared with the first. Heart rate Calculations of the mean values showed
The perceived exertion, angina pectoris, dyspnoea, that metoprolol at both dose levels produced and sensation of fatigue in the legs were not signia significant reduction in resting heart rate, heart ficantly affected, by either dose of metoprolol. rate recorded at comparable work load, and heart Cardiac volume, calculated as total volume, rate at the end of exercise, compared with placebo showed no significant differences at the end of the The effect was greater at the higher dose.
treatment periods with metoprolol 50 mg t. prolol. Thus, one patient had 25 mg t.d.s. and the results of treatment with 50 mg t.d.s. relative to remainder had 50 mg t.d.s. Patients were examined treatment with 20 mg t.d.s. of metoprolol. Thereafter 6, 12, 18, and 24 months' treatment with fore, from the results of the present investigation metoprolol. The following laboratory investigations it is difficult to state which of the two dosage levels were done: haemoglobin, white blood cell count, used is the optimal one. and ESR; serum creatinine, bilirubin, alkaline However, if only the median and mean values are phosphatase, AST, ALT, cholesterol, triglycerides, taken into consideration, there was an improvement uric acid, and antinuclear factor (ANF). during the 50 mg t.d.s. treatment period compared During the long-term tolerance study, one patient with the 20 mg t.d.s. period. These results suggest had a non-fatal myocardial infarction. In the whole that 20 mg t.d.s. is a suitable initial dose of metogroup no severe unwanted effects were observed prolol, and that many patients derive further and there were no abnormal laboratory findings. benefit from 50 mg t.d.s. In this study, neither of the Blood pressure and body weight remained un-doses used induced any clinically significant unchanged throughout the study.
wanted effects nor were there any abnormal findings in the laboratory tests. Discussion
Both the increase in exercise tolerance and the subjective improvement indicate that metoprolol is This study was performed to evaluate the anti-effective in angina as are other beta-adrenergic anginal effect of metoprolol in 16 patients pre-blocking agents (Dagenais, Pitt, and Ross, 1971; viously 
